Government signs deal to see huge investment in mRNA vaccine manufacturing which could help tackle the next pandemic and ...

Cambridge is set to become home to a major new research and development hub as part of a £1bn UK investment by biopharmaceutical firm BioNTech, expected to create more than 400 ...

Shares of Vaccine stocks are moving higher on Tuesday after documents from the U.S. Food and Drug Administration revealed ...

BioNTech’s investment provides a template for UK growth, say ABPI The innovative biopharmaceutical company BioNTech has announced a major investment of up to £1bn over 10 years in the UK, potentially ...

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

(Reuters) -Advisers to the U.S. Food and Drug Administration will discuss recommendations for updated COVID-19 vaccines ahead ...

BioNTech said it plans to invest up to 1 billion pounds ($1.34 billion) over the next 10 years to expand its research and development activities for innovative medicines in the U.K.

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

Pfizer jumps into cancer-treatment race with a $6 billion licensing deal with a China-based company, six months after Merck’s ...

Pfizer will pay China’s 3SBio $1.25 billion upfront to gain access to a cancer therapy that could rival Akeso and Summit’s ...

Biopharmaceutical company BioNTech has announced funding of up to £1 billion into the UK over the next 10 years. The planned investment would be one of the biggest in the history of UK life sciences, ...